6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Oorspronkelijke tekst

Deze vertaling beoordelen

Je feedback wordt gebruikt om Google Translate te verbeteren

Latest Press Releases

Time	Headline
6m ago	ProWood TrueFrame Joist Now Available Across Northeast, South Atlantic
6m ago	Parker to Acquire CIRCOR’s Commercial and Defense Aerospace Business
6m ago	Toll Brothers Announces Cedar Terrace Community Now Open in Chantilly, Virginia
7m ago	When Blood Compatibility Becomes a Pregnancy Risk
7m ago	Tony and Grammy Award-Winning Leslie Odom, Jr. to Headline Blackbaud's bbcon 2026 Social Impact Tech Conference

About

1.51USD-0.04 -2.54%

Closed • Updated at 13:54 GMT+00:00

Market Cap$91.12M

Volume30.5K

Beta2.67

RSI33.48

Health TechnologyBiotechnology

Aldeyra Therapeutics, Inc. — investor relations, events, news, and company updates on 6ix.

Latest News

Aldeyra Therapeutics to Participate in the Oppenheimer 36th Annual Healthcare Life Sciences Conference

Aldeyra Therapeutics Announces PDUFA Extension of the New Drug Application of Reproxalap for the Treatment of Dry Eye Disease

Aldeyra Therapeutics Announces Expansion of RASP Platform to Include Central Nervous System Diseases and Provides Updates on Reproxalap at Research & Development Webcast

Aldeyra Therapeutics to Participate in the Jefferies Global Healthcare Conference in London

Aldeyra Therapeutics to Host Research & Development Update Webcast Event Scheduled for Thursday, November 13 at 8:00 a.m. ET

Community Chat

Ask AI